Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / *W EXP 09/24/202
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
2,491,723
-
Shares change
-
+2,491,723
-
Total reported value, excl. options
-
$3,670,000
-
Value change
-
+$3,670,000
-
Number of buys
-
16
-
Price
-
$1.48
Significant Holders of Jasper Therapeutics, Inc. - *W EXP 09/24/202 (JSPRW) as of Q3 2021
16 filings reported holding JSPRW - Jasper Therapeutics, Inc. - *W EXP 09/24/202 as of Q3 2021.
Jasper Therapeutics, Inc. - *W EXP 09/24/202 (JSPRW) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,491,723 shares
.
Largest 10 shareholders include Owl Creek Asset Management, L.P. (672,057 shares), HIGHBRIDGE CAPITAL MANAGEMENT LLC (608,436 shares), TENOR CAPITAL MANAGEMENT Co., L.P. (250,000 shares), Shaolin Capital Management LLC (205,261 shares), UBS OCONNOR LLC (179,723 shares), ZAZOVE ASSOCIATES LLC (124,993 shares), Maven Securities LTD (100,000 shares), RIVERNORTH CAPITAL MANAGEMENT, LLC (89,596 shares), Walleye Capital LLC (80,684 shares), and Bulldog Investors, LLP (47,887 shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.